Drugs Made In America Acquisition Corp. Units
$10.79
+0.00 (+0.00%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -1.8%
- 3 Months
- +0.7%
- YTD
- +2.9%
- 1 Year
- +1.8%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 11.6%
- Largest decline max drawdown, since Aug 2025
- -6.3%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.21
Own DMAAU?
See how DMAAU contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.